Concor 10 mg 30 tablets

Tradename

Concor

Concor

Compound:

Bisoprolol fumarate 10 mg

Auxiliary components:

microcrystalline cellulose, corn starch, croscarmellose sodium, magnesium stearate, colloidal silicon dioxide.

Properties

Selective beta1-blocker without intrinsic sympathomimetic activity, does not have membrane-stabilizing activity. Reduces the activity of plasma renin, reduces myocardial oxygen demand, reduces heart rate (at rest and during exercise) and cardiac output, while the stroke volume does not significantly decrease. Inhibits AV conduction. It has antianginal and hypotensive effects. In high doses, it can cause a blockade of β2-adrenergic receptors, mainly in the bronchi and vascular smooth muscles.

The antihypertensive effect is associated with a decrease in the minute blood volume, sympathetic stimulation of peripheral vessels, a decrease in the activity of the renin-angiotensin system (it is of greater importance for patients with initial renin hypersecretion), restoration of sensitivity in response to a decrease in blood pressure and an effect on the central nervous system.

The antianginal effect is due to a decrease in myocardial oxygen demand as a result of a decrease in heart rate and a decrease in contractility, an increase in diastole, and an improvement in myocardial perfusion.

Indications

Arterial hypertension, prevention of angina attacks, chronic heart failure.

Method of administration and dosage:

The optimal dosage regimen is determined by the doctor. It is necessary to strictly observe the compliance of the used dosage form of a particular drug with the indications for use and the dosage regimen.

Contraindications

Acute heart failure, chronic heart failure in the stage of decompensation, cardiogenic shock, collapse, AV block II and III degree (without a pacemaker), SSSU; sinoatrial blockade, severe bradycardia (heart rate <50 beats / min), Prinzmetal’s angina, marked decrease in blood pressure (systolic blood pressure <90 mm Hg), severe forms of bronchial asthma and COPD in history, late stages of peripheral circulatory disorders, Raynaud’s disease , pheochromocytoma (without the simultaneous use of alpha-blockers), metabolic acidosis, concomitant use of MAO inhibitors (except for MAO inhibitors of type B), children and adolescents under 18 years of age, hypersensitivity to bisoprolol and other beta-blockers.

Precautionary measures:

Use with caution in psoriasis and with indications of psoriasis in the family history, diabetes mellitus in the decompensation phase, with a predisposition to allergic reactions. With pheochromocytoma, the use of bisoprolol is possible only after taking alpha-blockers. Avoid sudden cancellation of bisoprolol, the course of treatment should be completed slowly with a gradual dose reduction. Before surgery, the anesthesiologist should be informed about the treatment with bisoprolol.

Side effects

From the nervous system: weakness, fatigue, dizziness, headache, sleep disorders, mental disorders (depression, rarely hallucinations), feeling of cold and paresthesia in the extremities.

On the part of the cardiovascular system: orthostatic hypotension, bradycardia, impaired AV conduction, the appearance of symptoms of heart failure, aggravation of intermittent claudication and the main clinical symptoms in Raynaud’s syndrome.

From the side of the organ of vision: a decrease in the secretion of lacrimal fluid, conjunctivitis.